BioGaia AB (CHIX:BIOGBS) E10: kr3.01 (As of Mar. 2026)


CHIX:BIOGBS BioGaia AB CHIX:BIOGBS
100 GF Score
Price kr120.20
GF Value kr128.61
! 5 Warning Signs
View Full Analysis

What is BioGaia AB E10?

BioGaia AB CHIX:BIOGBS 100 E10 is kr3.01 as of Mar. 2026. GuruFocus rates CHIX:BIOGBS with a GF Score™ of 100/100 and a GF Value™ of kr128.61. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BioGaia AB's adjusted earnings per share data for the three months ended in Mar. 2026 was kr0.780. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr3.01 for the trailing ten years ended in Mar. 2026.

During the past 12 months, BioGaia AB's average E10 Growth Rate was 2.00% per year. During the past 3 years, the average E10 Growth Rate was 8.60% per year. During the past 5 years, the average E10 Growth Rate was 9.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of BioGaia AB was 10.90% per year. The lowest was 8.20% per year. And the median was 9.30% per year.

As of today (2026-06-29), BioGaia AB's current stock price is kr120.20. BioGaia AB's E10 for the quarter that ended in Mar. 2026 was kr3.01. BioGaia AB's Shiller PE Ratio of today is 39.93.

During the past 13 years, the highest Shiller PE Ratio of BioGaia AB was 61.09. The lowest was 30.97. And the median was 42.34.


BioGaia AB  (CHIX:BIOGBs) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

BioGaia AB's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=120.20/3.01
=39.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of BioGaia AB was 61.09. The lowest was 30.97. And the median was 42.34.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


BioGaia AB E10 Related Terms


BioGaia AB E10 Historical Data

* Premium members only.

The historical data trend for BioGaia AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioGaia AB E10 Chart

BioGaia AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.21 2.56 2.70 2.56 3.13

BioGaia AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.61 2.82 3.12 3.13 3.01

CHIX:BIOGBS vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGaia AB Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Shiller PE Ratio falls into.


CHIX:BIOGBS
100GF Score
BioGaia AB CHIX:BIOGBS
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioGaia AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioGaia AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.78/133.3862*133.3862
=0.780

Current CPI (Mar. 2026) = 133.3862.

BioGaia AB Quarterly Data

per share eps CPI Adj_EPS
201606 0.444 101.019 0.586
201609 0.404 101.138 0.533
201612 0.542 102.022 0.709
201703 0.494 102.022 0.646
201706 0.544 102.752 0.706
201709 0.486 103.279 0.628
201712 0.558 103.793 0.717
201803 0.498 103.962 0.639
201806 0.644 104.875 0.819
201809 0.594 105.679 0.750
201812 0.740 105.912 0.932
201903 0.412 105.886 0.519
201906 0.704 106.742 0.880
201909 0.438 107.214 0.545
201912 0.588 107.766 0.728
202003 0.482 106.563 0.603
202006 0.904 107.498 1.122
202009 0.234 107.635 0.290
202012 0.404 108.296 0.498
202103 0.500 108.360 0.615
202106 0.540 108.928 0.661
202109 0.520 110.338 0.629
202112 0.380 112.486 0.451
202203 0.760 114.825 0.883
202206 0.780 118.384 0.879
202209 0.790 122.296 0.862
202212 1.380 126.365 1.457
202303 1.150 127.042 1.207
202306 0.800 129.407 0.825
202309 1.010 130.224 1.035
202312 0.670 131.912 0.677
202403 1.210 132.205 1.221
202406 1.100 132.716 1.106
202409 0.360 132.304 0.363
202412 0.810 132.987 0.812
202503 0.790 132.825 0.793
202506 0.870 133.699 0.868
202509 0.650 133.482 0.650
202512 0.980 133.386 0.980
202603 0.780 133.386 0.780

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of kr3.01 mean?
BioGaia AB (CHIX:BIOGBS) has a E10 of kr3.01 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on BioGaia AB and its competitors.
Is BioGaia AB's E10 too high?
BioGaia AB's current E10 is kr3.01. Overall, BioGaia AB has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does BioGaia AB's E10 compare to ZTS and UTHR?
BioGaia AB's E10 of kr3.01 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on BioGaia AB and its competitors. BioGaia AB's current E10 is kr3.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioGaia AB stock overvalued right now?
BioGaia AB (CHIX:BIOGBS) has a current E10 of kr3.01. The stock's GF Value™ is kr128.61, compared to a current price of kr120.20 — trading 6.5% below its estimated fair value. The current E10 is kr3.01. BioGaia AB's overall GF Score™ is 100/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For BioGaia AB (CHIX:BIOGBS), the current E10 is kr3.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioGaia AB (CHIX:BIOGBS) Overvalued in 2026?

Based on GuruFocus' analysis, BioGaia AB stock appears to be undervalued. The current stock price of kr120.20 is trading 6.5% below its estimated GF Value™ of kr128.61.

Key valuation signals for CHIX:BIOGBS:

  • E10: kr3.01
  • GF Value™: kr128.61 vs. price of kr120.20 (6.5% below fair value)
  • GF Score™: 100/100 with 5 warning signs

No single metric tells the full story. See the CHIX:BIOGBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioGaia AB Business Description

Address Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions: EMEA, the Americas, and APAC (Asia-Pacific, Australia, and New Zealand).
100GF Score

Get the complete analysis for CHIX:BIOGBS

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr120.20
Price
kr128.61
GF Value